trial · primary record
Empasiprubart IV
Guillain-Barré Syndrome (GBS)
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 63 |
| Primary completion | 2029-03 |
| Primary endpoint | Proportion of Participants With a Guillain-Barré Syndrome Disability Scale (GBS-DS) Score ≤2 at Week 4 |
| Registry ID | NCT07821762 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:42:52.242Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07821762
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Empasiprubart Iv · compound